February 11, 2026 – Researchers have identified a promising new speech biomarker that could significantly enrich clinical trials by reducing sample size requirements and enhancing statistical outcomes ...
Neurological diseases, including stroke, amyotrophic lateral sclerosis (ALS), and Parkinson’s disease, often cause dysarthria, which is a debilitating motor-speech disorder that disrupts neuromuscular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results